I must stress that this is a corporate presentation so sugar coated. And early days/limited trail numbers.
However I post to give hope to everyone that there are some exciting developments in the pipeline. CPI - 0610 might be superior to Ruxo because, allegedly, disease modifying ie able to improve marrow fibrosity, anaemia and reduce transfusion dependency.
Might even be a step towards that elusive ‘cure’? But very early days.....